An increasing number of cyclic dipeptides (CDPs) have been shown to exhibit important biological activity including antifungal, antibacterial, anticonvulsant and immunomodulatory activity. Furthermore, some CDP derivatives have been shown to exhibit antitumour activity in vitro and in vivo. Several proline-based CDPs that exhibit biological activity have been detected in various processed foods and beverages. In the present study, the potential of seven proline-based CDPs to inhibit cancer cell growth was investigated in HT-29 (colon), HeLa (cervical), MCF-7 (breast) and WHCO3 (oesophageal) cancer cell lines. The CDPs used in this study were cyclo(Phe-Pro), cyclo(Tyr-Pro), cyclo(Gly-Pro), cyclo(Pro- Pro), cyclo(His-Pro), cyclo(Leu-Pro) and cyclo(Thr-Pro). The sulforhodamine B (SRB) cell growth assay was used in an initial screening phase to investigate the effects of the CDPs in HT-29, HeLa and MCF-7 cells. After exposing the cells to 10mM of the respective CDPs for 48 hours, the SRB assay results showed that only cyclo(Phe-Pro) exhibited more than 50% growth inhibition (p<0.01) in the three cell lines. The other CDPs showed comparatively marginal growth-inhibitory effects, except for cyclo(Tyr-Pro), which exhibited a pronounced effect in MCF-7 cells compared to HT-29 and HeLa cells. The MTT assay was used to confirm the SRB assay results for cyclo(Phe-Pro) and cyclo(Tyr-Pro), extending the investigation to the use of the fourth cell line WHCO3 and using a longer exposure time of 72 hours. The MTT assay demonstrated a dosedependent (0.008-10 mM) growth inhibition by cyclo(Phe-Pro) with an IC50 value of 4.04 ± 1.15 mM for HT-29 cells. Cyclo(Phe-Pro) was subsequently used to investigate whether the growth-inhibitory effects of this CDP were related to the induction of apoptosis in HT-29 cells. Hoechst 33342 staining showed that 5mM cyclo(Phe-Pro) induced characteristic chromatin condensation and nuclear fragmentation in 18.3 ± 2.8% (p<0.01) of HT-29 cells after 72 hours. Furthermore, annexin V binding revealed that HT-29 cells treated with 5 mM cyclo(Phe-Pro) displayed phosphatidylserine externalization after 48 hours. In addition, it was shown that 10 mM cyclo(Phe-Pro) induced poly(ADP-ribose)polymerase PARP cleavage, one of the hallmark events of apoptosis. The use of the broad-range caspase inhibitor Z-VAD-FMK, showed that this PARP cleavage was caspase-dependent, which in turn was confirmed by demonstrating an increase in caspase-3 activity (p<0.01) in cyclo(Phe- Pro)-treated HT-29 cells. In conclusion, these findings demonstrate that cyclo(Phe-Pro) inhibited the growth of HT- 29, MCF-7, HeLa and WHCO3 cells, and induced apoptosis in HT-29 colon cancer cells, suggesting the potential antitumour activity of cyclo(Phe-Pro)-related CDPs.

Cancer is the second leading cause of death in the western world. In order to treat various types of cancer, platinum-based drugs are most widely employed as metal-containing chemotherapeutic agents. However, their clinical usage is hindered by toxic side effects, and by the emergence of drug resistance. Our focus was to replace platinum with less toxic metal like tin which can give better alternatives for cancer treatment. The major aim of our study was to synthesize novel organotin polyethers (Sn-O) which can be used to combat cancer. Preliminary results from our laboratory using organotin polyethers, that were synthesized by varying the structure of diols showed growth inhibition in Balb-3T3 cells. This study directly led us to hypothesize the two structural windows, first by changing the distance between diol and second, by presence of unsaturation in diols, the biological activity of organotin polyethers (Sn-O) can be enhanced significantly. Different series of polymeric compounds were synthesized based upon these two structural windows and the formation of products was validated using standard techniques like infrared spectroscopy (IR), light scattering photometer, matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS) and nuclear magnetic resonance (NMR). The synthesized polymers arrested the growth of cancer cell lines including bone, prostate, colon, breast, pancreas and lung cancer derived cell lines in vitro. In number of instances where chemotherapeutic index values of two and greater were found that these polymers are significantly more active against cancer cells than non-cancerous cells in culture. / These results support the starting premise that the polymers may exhibit cancer cell selectivity. In general, it was found that the presence of unsaturation increased the probability that the polyether would inhibit the growth of various cancer cell lines. Further, in some cases, polyethers with short distances between the oxygen atoms showed a superior ability to inhibit the growth of various cancer cell lines in comparison to those with longer distances between the oxygen atoms. These results provide a framework for the discovery of novel cancer therapeutics. / by Girish Vallabhbhai Barot. / Thesis (Ph.D.)--Florida Atlantic University, 2009. / Includes bibliography. / Electronic reproduction. Boca Raton, Fla., 2009. Mode of access: World Wide Web.

Nous proposons un modèle d’automate pour le cycle cellulaire lié à l’horloge circadienne. Ce modèle est utilisé pour déterminer la toxicité de différents schémas d’administration d’agents anticancéreux selon un profil temporel déterminé, dans le but d’optimiser l’efficacité de la chronothérapie des cancers. Fondé sur les transitions séquentielles entre les phases successives du cycle cellulaire G1, S (réplication de l’ADN), G2 et M (mitose), le modèle permet de simuler la distribution des phases du cycle cellulaire et son entraînement par l’horloge circadienne. Le modèle est utilisé pour évaluer l’effet du profil d’administration circadienne de deux agents anticancéreux, le 5-fluorouracile (5-FU) et l’oxaliplatine (l-OHP). Ces médicaments diffèrent par leur mode d’action mais sont complémentaires dans le traitement du cancer colorectal. Le 5-FU, considéré en premier, exerce ses effets cytotoxiques sur les cellules en phase S. Divers profils d’administration circadienne sont comparés, qui diffèrent par le temps du maximum d’administration du 5-FU. Le modèle explique pourquoi un minimum de cytotoxicité est obtenu lorsque le temps du pic d’administration approche 4h du matin, ce qui correspond au profil temporel d’administration utilisé en pratique clinique pour le 5-FU. Nous montrons comment la cytotoxicité de l’agent anticancéreux est affectée par la variabilité de la durée des phases du cycle cellulaire et par la durée du cycle cellulaire en présence et en absence d’entraînement par l’horloge circadienne. Les résultats indiquent qu’un même profil temporel d’administration peut avoir une cytotoxicité minimale pour une population cellulaire (correspondant à une population de cellules saines), et une cytotoxicité élevée pour une seconde population (correspondant à des cellules tumorales). Ainsi le modèle permet de mettre en lumière les mécanismes susceptibles d’améliorer simultanément la chronotolérance et la chronoefficacité des agents anticancéreux. Le cas de l’oxaliplatine (l-OHP) est considéré dans un second temps. Contrairement au 5-FU, l’oxaliplatine élimine les cellules quelle que soit sa phase dans le cycle cellulaire. La phamacocinétique des thiols plasmatiques et du glutathion intracellulaire est incorporée au modèle. Ces composés interfèrent avec l’action de l’OHP en formant des complexes inactifs. Le modèle montre comment des variations circadiennes dans la cytotoxicité de l-OHP peuvent résulter de rythmes circadiens dans les niveaux de thiols plasmatiques et de glutathion. En accord avec les résultats expérimentaux et cliniques, les simulations numériques du modèle d’automate pour le cycle cellulaire montrent que les profiles temporels minimisant la cytotoxicité de l’oxaliplatine sont en antiphase avec ceux minimisant la cytotoxicité du 5-fluorouracile./We propose an automaton model for the cell cycle coupled to the circadian clock. We use this model to assess the toxicity of various circadian patterns of anticancer drug delivery so as to enhance the efficiency of cancer chronotherapy. Based on the sequential transitions between the successive phases G1, S (DNA replication), G2, and M (mitosis) of the cell cycle, the model allows us to simulate the distribution of cell cycle phases as well as its entrainment by the circadian clock. We use the model to evaluate circadian patterns of administration of two anticancer drugs, 5-fluorouracil (5-FU) and oxaliplatin (l-OHP). These drugs, which differ by their mode of action, are complementary in the clinical treatment of colorectal cancer. We first consider the case of 5-FU, which exerts its cytotoxic effects on cells in S phase. We compare various circadian patterns of drug administration differing by the time of maximum drug delivery. The model explains why minimum cytotoxicity is obtained when the time of peak delivery is close to 4 a.m. which corresponds to the temporal pattern of administration used clinically for 5-FU. We also determine how cytotoxicity is affected by the variability in duration of cell cycle phases and by cell cycle length, in the presence or absence of entrainment by the circadian clock. The results indicate that the same temporal pattern of drug administration can have minimum cytotoxicity toward one cell population, e.g. of normal cells, and at the same time can display high cytotoxicity toward a second cell population, e.g. of tumour cells. Thus, the model allows us to uncover factors that may contribute to improve simultaneously chronotolerance and chronoefficacy of anticancer drugs. We next consider the case of oxaliplatin (l-OHP), which, in contrast to 5-FU, kills cells in different phases of the cell cycle. We incorporate into the model the pharmacokinetics of plasma thiols and intracellular glutathione, which interfere with the action of the drug by forming with it inactive complexes. The model shows how circadian changes in l-OHP cytotoxicity may arise from circadian variations in the levels of plasma thiols and glutathione. Corroborating experimental and clinical results, the numerical simulations of the automaton model for the cell cycle account for the observation that the temporal profiles minimizing l-OHP cytotoxicity are in antiphase with those minimizing cytotoxicity for 5-FU.<p> / Doctorat en Sciences agronomiques et ingénierie biologique / info:eu-repo/semantics/nonPublished